Christelle Masdeu, PhD
Chief Operating Officer
Christelle Masdeu has over 15 years of experience in business development and technology transfer within the biotechnology sector, having worked in both academic and private organizations. She has a proven track record of successfully leading licensing projects and establishing strategic agreements with major players in the pharmaceutical industry worldwide.
Before joining Valour Bio, Christelle spent six years at the Tech Transfer Office of the Institut Curie, where she managed the technology transfer of all projects related to immuno-oncology, particularly the single-domain antibody platform developed by Sandrine Moutel and Franck Perez at the origin of the spin-off Emglev where she served as CEO of the company.
Prior to her time at the Institut Curie, Christelle held senior positions at Genethon and Cellectis, focusing on establishing strategic partnerships, co-development agreements, and licensing therapeutic products and technologies.
Christelle holds a PhD in Cancer Biology from the University of Paris XI, funded by Biogen Idec, and completed her postdoctoral research at the Institute of Myology (Pitié-Salpêtrière Hospital).